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Objective: We studied the fate of the ipsilateral external carotid artery (ECA) after stenting of the internal carotid artery
(ICA) compared with the contralateral ECA.
Subjects and Methods: One hundred twenty-one ipsilateral ECAs in 112 consecutive patients who underwent carotid artery
Wallstent placement were prospectively studied with color-coded duplex sonographic scanning (CCDS) and compared with 83
contralateral ECAs over 2 years. CCDS was scheduled for the day before (day 0), the day after (day 1) and 3, 6, 12, and 24
months after stenting. Development of ECA occlusive disease was evaluated with ECA–common carotid artery flow ratio (peak
systolic velocity). For estimation of ECA stenosis 70% or greater, flow ratio 4.1 was used as the cutoff point.
Results: Before and after stenting, two and three (one additional) ECA occlusions were seen. Median grade of ECA
stenosis on day 1 did not significantly change at angiography (P 1.0; tendency of increase) or CCDS (P .27; tendency
of decrease).
At follow-up (day 1-24 months, CCDS only), frequency of stenosis 70% or greater in the ipsilateral ECA was 21 of 120
(17.5%) on day 1 and 41 of 107 (38.32%) at 24 months, and 3 of 107 (2.5%) and 5 of 107 (4.67%) ECA occlusions were
registered at the two time points. Progression of disease, as demonstrated by increase in flow ratio over time, was much
more pronounced in the ipsilateral ECAs compared with the contralateral ECAs (P  .0002).
In stented ICA, 2 (1.85%) asymptomatic recurrent stenoses 70% or greater were found at CCDS.
One of three patients with new ECA occlusions reported jaw claudication for 10 days. Perioperative stroke (one major, four
minor) occurred in 5 of 121 patients (4.46%). Two minor strokes caused by embolization occurred during the first year.
Conclusion: The more pronounced progression of arteriosclerotic disease at the orifice of the ipsilateral ECAs during the
first year after carotid stenting might be due to local factors of the ICA stent. Its clinical significance in respect to the effect
of the ECA as collateral supply to the brain might depend on the incidence of carotid stent rerecurrent stenosis, which was
low in the present study. (J Vasc Surg 2003;38:1039-44.)
Over the last few years carotid artery stenting has
emerged as a possible alternative to surgical treatment, but
is still controversial.1-3 Complications and recurrent steno-
sis rates, and management of recurrent stenosis are reported
disadvantages of the method.1-4 Complications and recur-
rent stenosis rates were investigated in several single-center
studies5-8 and with the global questionnaire survey of
Wholey et al,9 and are comparable with those reported for
carotid endarterectomy.10-12
Most high-grade arteriosclerotic lesions are located at
the carotid bifurcation, usually at the distal common ca-
rotid artery (CCA) and the proximal internal carotid artery
(ICA), and frequently the external carotid artery (ECA) is
also involved. Therefore stents are usually placed across the
bifurcation from the CCA, extending into the ICA (Fig 1).
That the stent covers the orifice of the ECA might be a
further argument against carotid stenting. The ECA may
provide a collateral pathway in patients with ICA occlusion
or stenosis. Therefore, in the course of surgery on the ICA,
many surgeons include the ECA. Furthermore, the fate of
the ipsilateral ECA has been investigated with13 and with-
out14 additional external carotid endarterectomy. To our
knowledge, data concerning the effect of carotid stent
placement on the ipsilateral ECA immediately after the
procedure and during follow-up have not been published.
We used duplex ultrasound scanning to investigate the
fate of the ECA after carotid stenting in a prospective study.
Over 24 months, 121 consecutive carotid stents were ex-
amined in 112 patients. Two questions were addressed:
What is the prevalence of primary stenosis and occlusion of
the ipsilateral and contralateral ECA before carotid stent
placement, and how does further development of arterial
occlusive disease in the ipsilateral ECA immediately after
the stenting procedure and during follow-up compare with
the contralateral side?
METHODS
Patients. From January 1997 to November 1998, 121
carotid arteries in 112 consecutive patients (77 men) were
successfully stented, in accordance with a previously de-
scribed technical protocol.15 The study, which complied
with the Declaration of Helsinki, was approved by the local
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ethics committee, and all patients enrolled in the study gave
written informed consent.
Nine patients underwent bilateral stenting, 6 of them in
the same session. No brain-protective antiembolic device
was used in this early series, but is applied as a standard
today. Self-expanding Wallstents (Boston Scientific,
Natick, Mass) with a rolling membrane (carotid stents
1-102) and Easy Wallstents (Boston Scientific) were used
throughout the study.
The stents were sized according to estimation of the
diameter of the carotid artery using the selective angio-
gram. The size of the balloon catheter was 5 to 6 mm.
Patients were prospectively followed up with color-
coded duplex ultrasound scanning (CCDS) to study hemo-
dynamic parameters of the ECA over 24 months. Fol-
low-up visits were scheduled for day 1 after the intervention
and at 3, 6, 12, and 24 months after stent placement, and at
any time in the event of neurologic symptoms.
Concomitant medical therapy. The purpose of such
treatment was to optimize risk factors such as hypertension,
hyperlipidemia, metabolic state in diabetes mellitus, or
cigarette smoking and to provide standardized antiplatelet
therapy. Antiplatelet therapy consisted of 250 mg of ticlo-
pidine administered twice a day, plus acetylsalicylic acid
(ASA), 100 mg/d. ASA was discontinued after 4 weeks.
Ticlopidine was continued for 1 year,16,17 after which ASA,
100 mg/d, was resumed. Similar or identical regimens have
been successfully used with carotid stenting.15,18
Color-coded duplex ultrasound scanning. All du-
plex ultrasound scanning was performed with a Vingmed
System 5 (Vingmed Sound AIS [now General Electric],
N-3191; Horton, Norway), with a 10-MHz linear array
transducer (axial resolution, 0.2 mm). All examinations
were performed by two experienced sonographers (A.W.,
A.F.). Settings for depth gain compensation, dynamic
range, frame rate, and persistence were held constant.
Depth, gain, and magnification were adjusted according to
patient anatomy.
All data were collected prospectively. In all examina-
tions, standard longitudinal color-coded flow and B-mode
images were obtained. In addition, color print data were
stored in a digital data base (Clinical Win Data; E and L Co,
Erlangen, Germany).
Grading of ECA stenosis. Fast Fourier transform
curves of standard sites were recorded, as follows. With
respect to the ipsilateral ECA, after stenting of the ICA, fast
Fourier transform curves of the following standard sites
were recorded: from the CCA, a few millimeters from the
proximal edge within the stent, and from the ECA outside
the stent a few millimeters distant to it or at the point of
maximal velocity in case of stenosis. With respect to the
contralateral and ipsilateral ECA before stenting, the fol-
lowing sites served as references: CCA 3 cm proximal to the
bifurcation, and ECA a few millimeters distal to its origin or
at the site of maximal peak systolic velocity (PSV). PSV and
end- diastolic velocity (EDV) were recorded at every site.
From these values, the ECA flow ratio was calculated as
Maximal PSV of ECA
PSV of CCA
.
Grading of stenosis was based on angiographic evaluation
of the ECA before and after stenting, which was correlated
with the flow ratio. In this series, angiographic grading of
ECA stenosis had been done analogous to the procedure
used for ICA stenosis in the North American Symptomatic
Carotid Endarterectomy Trial (NASCET).10 Diameter 1
(D1) of the ECA a few millimeters distal to the stent or at its
maximal narrowing in case of stenosis was compared with
diameter 2 (D2) of the ECA distal to it, but before its first
branching. The degree of stenosis or diameter reduction
(DR) was calculated as
DR  100  (D1/D2  100).
The Pearson coefficient of correlation between angio-
graphic diameter reduction and ECA flow ratio was 0.73 (P
 .01). For a 70% reduction in diameter on angiograms, a
discriminating value of ECA flow ratio of 4.1 at CCDS had
sensitivity of 93.9% and specificity of 92.6%; positive pre-
dictive value was 67.4%, and false predictive value was
98.9%. Therefore flow ratio of 4.1 or greater was the basis
for estimation of ECA stenosis 70% or greater, which is in
good agreement with published data.19
Statistical analysis. Inasmuch as most variables are
not normally distributed, the results are given as median,
and 25th and 75th percentiles. Numbers and percentages
were additionally used. In each patient, difference in flow
ratio between day 1 and 24-month follow-up was calcu-
lated separately for the ipsilateral and contralateral sides.
Moreover contralateral and ipsilateral ECA were compared
with nonparametric tests for matched data. Most of the
variables were highly skewed in terms of distribution; thus
Fig 1. Color-coded duplex scan of a carotid bifurcation 1 year
after stent implantation shows a typical high-grade stenosis at the
orifice of the external carotid artery (ECA), underlined by the fast
Fourier transform curve and by typical changes of color flow at the
orifice. Blue areas, narrowing; green areas, flow turbulence. White
arrows, stent; green arrows, orifice of ECA (stenosis) and fast
Fourier transform flow curve. Scale of flow velocity is given in
meters per second. Space between stent and perfused red lumen
represents neointima with some hyperplasia.
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the sign test was considered more appropriate than the
signed-rank test.
The same procedure was used to compare flow ratio
between day 1 and at 24 months for the ipsilateral ECA and
ICA. A two-sided P value less than .01 was considered
significant because of multiple testing.
All calculations and graphs were produced with the SAS
system (SAS, Chicago, Ill).
RESULTS
Mean age of the 112 patients (77 men) was 69  10
(SD) years. Their mean body mass index was 26 4 (SD).
Risk factors included arterial hypertension in 93 patients
(83%), diabetes mellitus in 43 patients (38.4%), cigarette
smoking in 64 patients (57%), and hyperlipidemia in 94
patients (84%).
In 107 of 121 consecutively stented carotid arteries (98
of 112 patients), scheduled follow-up with CCDS was
concluded after 24 months. Fourteen carotid arteries or pa-
tients were lost to follow-up: 9 because of non-intervention-
related death; 4 because of technical problems, such as exten-
sive shadowing or high bifurcation, and because exact
measurements of hemodynamic parameters at the origin of
the ECA could not be performed; and 1 because of disabling
stroke after thoracic surgery 2 months after carotid stenting.
Median grade (25th, 75th percentile) of ICA stenosis
was 80% (72.5, 86.0) before the procedure and 2% (0, 12)
after the procedure, as evaluated with the NASCET
method on selected angiograms.
Immediate effect of carotid stenting on ipsilateral
ECA. The acute effect of carotid stenting on the ipsilateral
ECA was assessed by comparing angiograms obtained be-
fore and after stenting. ECA occlusion was noted in 2
arteries before stenting and 3 arteries (plus 1 additional
embolic symptomatic occlusion) immediately after stent-
ing. Median (25th, 75th percentiles) ipsilateral ECA diam-
eter at angiography was 23% (2.0, 61.0) before carotid
stenting versus 28.25% (4.8, 46.7) after carotid stenting.
This tendency of increasing degree of angiographic ECA
stenosis after stenting included 1 additional complete ECA
occlusion (100% stenosis) due to stenting, but did not
achieve statistical significance (P  .82).
Color-coded duplex ultrasound scanning. All an-
giographic ECA occlusions were correctly diagnosed at
duplex ultrasound scanning. With respect to ECA stenosis
of 70% or greater, 25 stenoses (20.7%) were identified with
duplex ultrasound scanning, compared with 24 stenoses
(19.8%) at angiography, before intervention. In contrast to
angiography, ECA median flow ratio decreased on day 1
after stenting, from 2.2 (1.5, 3.5) before intervention to
2.1 (1.4, 3.1) after intervention. This tendency was not
statistically significant (P  .27).
Follow-up from day 1 to 24 months was based exclu-
sively on data from duplex ultrasound scanning. This is
illustrated by an example of a typical high-grade stenosis of
the ipsilateral ECA at its origin, as found at CCDS at 1-year
follow-up (Fig 1).
Occlusion of ipsilateral ECA. Other than occlusion
in two ipsilateral ECAs before stenting and one occlusion
due to the stenting procedure, one additional occlusion
occurred after both 12 and 24 months (Table).
Stenosis of ipsilateral ECA. Overall development of
estimated ipsilateral ECA stenosis 70% or greater, on the
basis of flow ratio, is detailed in the Table. Estimated
incidence increased up to the 6-month follow-up and re-
mained rather stable up to the 24-month follow-up.
Contralateral ECA. Of 83 ECA on the non-stented
side, 1 (1.2%) demonstrated occlusion on day 0 (before the
intervention) and 8 (9.6%) had stenosis estimated at 70% or
greater. At 24 months, a minor increase was found (P 
.0001). Median flow ratio (25th, 75th percentiles) was
1.73 (1.3, 2.69) before stenting and 1.95 (1.5, 2.93) at 24
months; median individual difference was 0.305 (P 
.0011).
Comparison of ipsilateral versus contralateral
ECA. A comparison of progression of disease of the ipsi-
lateral ECA (n  119) and contralateral ECA (n  83), as
demonstrated by flow ratio, is shown in Fig 2, A. On day 1,
flow ratio of the ipsilateral and contralateral ECA did not
differ significantly (P  .27). The dynamics of flow ratio/
disease over time is evident at 24 months. Compared with
day 1, the pronounced increase in the ipsilateral ECA (P
.00001) and the moderate increase in the contralateral
ECA (P .001) were significant. Furthermore, increase in
flow ratio was significantly higher in the ipsilateral ECA
than in the contralateral ECA (P  .00002).
To investigate the influence of possible progression of
stenosis within the ICA stent on the ipsilateral ECA, the
dynamics of their flow ratios were compared over time (Fig
Frequency and column percentage of 70% stenoses and occlusions of ipsilateral external carotid artery
Follow-up
Day 0 Day 1 3 Mo 6 Mo 12 Mo 24 Mo
n % n % n % n % n % n %
70% ECA stenoses* 25 20.66 21 17.50 22 19.29 40 35.71 39 36.11 41 38.32
Occlusions 2 1.65 3 2.50 3 2.63 3 2.70 4 3.70 5 4.67
N 121 120 114 112 108 107
ECA, External carotid artery; N, number of carotid arteries observed.
*Flow ratio, 4.1.
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2, B). In the stented ICA a moderate yet significant (P
.0000) increase in flow ratio included 2 high-grade stent
recurrent stenoses and indicated increased thickness of the
neointima (Fig 1). Again, the increase in flow ratio (day
1–24 months) was much more pronounced in the ipsilat-
eral ECA (P  .0006).
Concomitant clinical events. Characteristic symp-
toms were observed only in 1 of 3 new ECA occlusions. In
this case, occlusion of the ECA was due to embolism during
the stenting procedure, followed by a period of jaw claudi-
cation for up to 10 days.
The incidence of perioperative stroke in this series was
4.46% (one major stroke, four minor strokes). Minor
strokes occurred in two additional patients within the first
year after stenting, due to cardiogenic embolization.
Two high-grade (70%) asymptomatic stent recurrent
stenoses occurred within the first year after stenting.
DISCUSSION
Our results show that significant progression of arte-
rial occlusive disease, as reflected by an increase in ECA
flow ratio, in the ipsilateral ECA occurs after overstent-
ing (Fig 2, A). In the opposite ECA, only minor yet
significant increase in flow ratio was found (P .001). In
other words, there was greater progression of disease in
the ipsilateral ECA compared with the contralateral
ECA. Investigating the natural history of the ECA after
carotid endarterectomy without any intervention at the
ECA, Ascer et al14 reported a rather low overall primary
prevalence of severe ECA stenoses: 14% and 8% stenoses,
respectively, with diameter reduction of 50% to 69% and
70% or greater, respectively, no occlusions, and no sig-
nificant early or late influence of carotid endarterectomy
on arterial occlusive disease in the ipsilateral ECA. The
natural history of our contralateral ECA is comparable
with that reported by Ascer et al14 after surgery on the
ICA without any intervention at the ECA.
In contrast to the ICA, evaluations of degree of ECA
stenosis have been rarely described.13,14,19 In all of these
studies, duplex scan–based flow criteria were used. Ascer et
al14 and Archie13 used PSV of the ECA to grade ECA
stenosis. In a meticulously conducted study, Pa¨iva¨nsalo et
al19 found the peak systolic flow ratio ECA/CCA to be
superior for grading ECA stenosis; these authors report
mean flow ratio of 3.9  1.8 (SD) in stenosis of 70% or
greater. Our duplex scan–based evaluation is in good
agreement with that report. Pa¨iva¨nsalo et al19 reported, in
addition, that ICA stenosis is accompanied by a false in-
crease in ECA flow ratio in the normal ECA, and they
assume that the same applies to the stenosed ECA. This
indicates overestimation of grade of ECA stenosis with
duplex ultrasound scanning before stenting of high-grade
ICA stenoses, followed by a feigned drop in number of
ECA stenoses 70% or greater at day 1 after stenting, as
Fig 2. A, Box plots (median; 25th, 75th percentiles) show development of median flow ratio over follow-up of 24
months of the ipsilateral external carotid artery (unbroken line) compared with the contralateral external carotid artery
(dashed line). B, Box plots (median; 25th, 75th percentiles) show development of median flow ratio over follow-up of
24 months of the ipsilateral external carotid artery (unbroken line) compared with the ipsilateral stented internal carotid
artery (dashed line).
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shown in the Table and in the report by Ascer et al14 after
surgical removal of ICA stenosis.
As the ipsilateral ECA becomes an important source of
cerebral blood flow20 in the presence of occlusion or severe
stenosis of the ICA, especially in patients with an incom-
plete circle of Willis, many surgeons routinely perform
some kind of ECA endarterectomy during standard carotid
endarterectomy,13 to preserve ECA patency and thereby
collateral supply in cerebral perfusion in the event of recur-
rent stenosis. Archie,13 however, showed that carotid end-
arterectomy with a combination of the proximal eversion
technique and blind distal endarterectomy of the ECA
resulted in a greater frequency of stenosis and occlusion in
the early postoperative period.
In the present study, change in ECA flow ratio or
degree of stenosis in the contralateral ECA alone was
comparable with the natural history of the ECA after ca-
rotid endarterectomy in the report by Ascer et al.14
In our study, significantly higher progression of arterial
occlusive disease in the ipsilateral versus the contralateral
ECA after carotid stent placement occurred in the same
patients, with the same general risks for both sides. We
therefore assume that local factors may give rise to such
varied development. It can be reasonably assumed that the
disease and its progression would be more pronounced on
the stented side. This could apply to the ICA, which had
been stented, but could not be proved for the ipsilateral
ECA. No significant difference in flow ratio between the
ipsilateral and contralateral ECA was found on day 1 (P 
.27). The dynamics of increasing flow ratio were different in
the stented ICA and the ipsilateral ECA over time (P 
.0002).
Therefore local factors accompanying overstenting of
the ECA orifice might be considered. The nature of these
factors remains unclear. Flow turbulence caused by passage
through the meshes of the stent wall to the ECA might be
a plausible explanation for this enhanced narrowing of the
ECA. After 1 year, however, some kind of steady state
seems to be achieved.
The role of the ECA as a collateral support to the brain
in cases of stenting of the ICA is worthy of discussion. The
incidence of carotid stent recurrent stenosis has been re-
ported to be rather low, about 3.5% during the first 12
months, based on single-center experience21 with Wall-
stents and global experience with more than 5200 carotid
stents.9 This reduces the impact of the ECA as a source of
collateral supply to the brain in cases of carotid stenting. In
case of a higher incidence of carotid stent recurrent steno-
sis, as published in the Carotid and Vertebral Artery Trans-
luminal Angioplasty Study (CAVATAS),4 the dynamics of
ECA disease and the importance of the ECA as a collateral
vessel might be different. It should be emphasized, how-
ever, that the carotid stent group of CAVATAS included
only 41 patients with three different types of stents.
The clinical significance of greater progression of oc-
clusive disease in the ipsilateral ECA during the first year
after carotid stenting is limited. Only one patient with
presumed embolic ECA occlusion immediately after stent
placement had transient jaw claudication. Furthermore,
attempting to dilate an ECA stenosis during the stenting
procedure could give rise to brain embolism.
We recommend carotid stent placement according to
the guidelines of a consensus paper,22 with no intervention
at the ECA. This recommendation is in keeping with that
proposed by Ascer et al14 for carotid endarterectomy.
Our results are based on experience at a single center,
with Wallstents only. Although it is a prospective study with
meticulous clinical and CCDS follow-up of more than 100
carotid arteries, the duration of study is currently limited to
24 months.
REFERENCES
1. Beebe HG, Archie JP, Baker WH, Barnes RW, Becker GJ, Bernstein
EF, et al. Concern about safety of carotid angioplasty. Stroke 1996;
197-8.
2. Beebe HG, Kritpracha B. Carotid stenting versus carotid endarterec-
tomy: update on the controversy. Semin Vasc Surg 1998;11:46-51.
3. Brott TG. Angioplasty and stenting should be performed only in the
settings of a clinical trial. Stroke 2002;33:2519.
4. CAVATAS Investigators. Endovascular versus surgical treatment in
patients with carotid stenosis in the Carotid and Vertebral Artery
Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lan-
cet 2001;357:1729-37.
5. Theron JG, Payelle GG, Coskun O, Huet HF, Guimaraens L. Carotid
artery stenosis: treatment with protected balloon angioplasty and stent
placement. Radiology 1996;201:627-36.
6. Diethrich EB, Ndiaye M, Reid DB. Stenting in the carotid artery: initial
experience in 110 patients. J Endovasc Surg 1996;3:42-62.
7. Roubin GS, New G, Iyer SS, Vitek JJ, Al Mubarak N, Liu MW, et al.
Immediate and late clinical outcomes of carotid artery stenting in
patients with symptomatic and asymptomatic carotid artery stenosis: a
5-year prospective analysis. Circulation 2001;103:532-7.
8. Mathias K, Jager H, Gissler HM. Endovascular treatment of carotid
artery stenosis. Z Kardiol 2000;89:19-26.
9. Wholey MH, Wholey M, Mathias K, Roubin GS, Diethrich EB, Henry
M, et al. Global experience in cervical carotid artery stent placement.
Catheter Cardiovasc Interv 2000;50:160-7.
10. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB,
et al. Benefit of carotid endarterectomy in patients with symptomatic
moderate or severe stenosis. North American Symptomatic Carotid
Endarterectomy Trial Collaborators. N Engl J Med 1998;339:1415-
25.
11. European Carotid Surgery Trialists’ Collaborative Group. European
Carotid Surgery Trial: interim results for symptomatic patients with
severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991;
337:1235-43.
12. Gorlitzer M, Heine B, Mendel H, Gu¨nen E, Meinhart J, Sisel A, et al.
Redo surgery for carotid artery stenosis: when and how. Cardiovasc
Surg 2000;8:366-71.
13. Archie JP Jr. The outcome of external carotid endarterectomy during
routine carotid endarterectomy. J Vasc Surg 1998;28:585-90.
14. Ascer E, Gennaro M, Pollina RM, Salles Cunha S, Lorenson E, York-
ovich WR, et al. The natural history of the external carotid artery after
carotid endarterectomy: implications for management. J Vasc Surg
1996;23:582-6.
15. Ahmadi R, Willfort A, Lang W, Schillinger M, Alt E, Gschwandtner
ME, et al. Carotid artery stenting: effect of learning curve and
intermediate-term morphological outcome. J Endovasc Ther 2001;
8:539-46.
16. Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW,
et al. The Canadian American Ticlopidine Study (CATS) in thrombo-
embolic stroke. Lancet 1989;19:442-3.
17. Bogousslavski J. Benefit of ADP receptor antagonists in atherothrom-
botic patients: new evidence. Cerobrovasc Dis 2001;11:5-10.
JOURNAL OF VASCULAR SURGERY
Volume 38, Number 5 Willfort-Ehringer et al 1043
18. Bhatt DL, Kapadia SR, Bajzer CT, Chew DP, Ziada KM, Mukherjee D,
et al. Dual antiplatlet therapy with clopidogrel and aspirin after carotid
stenting. J Invas Cardiol 2001;13:767-71.
19. Pa¨iva¨nsalo MJ, Siniluoto TMJ, Tikkakoski TA, Myllyla¨ V, Suramo
IJI. Duplex US of the external carotid artery. Acta Radiol 1996;37:
41-5.
20. Jackson BB. The external carotid as a brain collateral. Am J Surg
1967;113:375-8.
21. Willfort-Ehringer A, Ahmadi A, Gschwandtner M, Haumer M, Lang
W, et al. Single-center experience with carotid stent restenosis. J Endo-
vasc Ther 2002;9:299-307.
22. Veith FJ, Amor M, Ohki T, Beebe HG, Bell PRF, Bolia A, et al. Current
status of carotid bifurcation angioplasty and stenting based on a con-
sensus of opinion leaders. J Vasc Surg 2001;33(suppl):S111-6.
Submitted Dec 9, 2002; accepted Mar 25, 2003.
JOURNAL OF VASCULAR SURGERY
November 20031044 Willfort-Ehringer et al
